Zhejiang Shengda Bio-Pharm Co., Ltd. once again obtained the API Certificate for exporting biotin to the EU. The certificate is valid from 2022 to 2025. This certificate proves that Shengda Bio-Pharm not only fully conforms with China's drug GMP requirements, but also meet the drug GMP requirements of the EU, WHO and ICH Q7. This helps open the gate for exporting pharmaceutical grade biotin to many other countries.